Trials / Recruiting
RecruitingNCT06605378
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
A Cross-Sectional, Observational Study of the Prevalence of Adenoviral-Specific Antibodies and Inflammatory Cytokines in Participants With Chronic Granulomatous Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Ensoma · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This research study is designed to assess the prevalence of specific antibodies and inflammatory cytokines in adult and pediatric participants with CGD.
Detailed description
In this observational study, blood samples will be collected from adult and pediatric patients with CGD. The level of circulating adenovirus antibodies and inflammatory cytokines will be measured to characterize the prevalence of these markers in this population.
Conditions
Timeline
- Start date
- 2024-11-18
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2024-09-20
- Last updated
- 2026-03-03
Locations
52 sites across 2 countries: United States, United Kingdom
Source: ClinicalTrials.gov record NCT06605378. Inclusion in this directory is not an endorsement.